492 related articles for article (PubMed ID: 2004104)
1. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
[TBL] [Abstract][Full Text] [Related]
2. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo.
Mori A; Klibanov AL; Torchilin VP; Huang L
FEBS Lett; 1991 Jun; 284(2):263-6. PubMed ID: 2060647
[TBL] [Abstract][Full Text] [Related]
3. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
4. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.
Litzinger DC; Buiting AM; van Rooijen N; Huang L
Biochim Biophys Acta; 1994 Feb; 1190(1):99-107. PubMed ID: 8110825
[TBL] [Abstract][Full Text] [Related]
5. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.
Klibanov AL; Maruyama K; Torchilin VP; Huang L
FEBS Lett; 1990 Jul; 268(1):235-7. PubMed ID: 2384160
[TBL] [Abstract][Full Text] [Related]
6. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen.
Litzinger DC; Huang L
Biochim Biophys Acta; 1992 Aug; 1127(3):249-54. PubMed ID: 1511002
[TBL] [Abstract][Full Text] [Related]
7. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol).
Maruyama K; Yuda T; Okamoto A; Kojima S; Suginaka A; Iwatsuru M
Biochim Biophys Acta; 1992 Sep; 1128(1):44-9. PubMed ID: 1390877
[TBL] [Abstract][Full Text] [Related]
8. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Li WM; Xue L; Mayer LD; Bally MB
Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091
[TBL] [Abstract][Full Text] [Related]
9. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
10. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L
Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866
[TBL] [Abstract][Full Text] [Related]
12. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome.
Ng K; Zhao L; Liu Y; Mahapatro M
Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778
[TBL] [Abstract][Full Text] [Related]
13. Distribution within the organs of a reticuloendothelial system of liposomes containing lipid A.
Park YS; Huang L
J Drug Target; 1993; 1(4):325-30. PubMed ID: 8069575
[TBL] [Abstract][Full Text] [Related]
14. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium.
Torchilin VP; Klibanov AL; Huang L; O'Donnell S; Nossiff ND; Khaw BA
FASEB J; 1992 Jun; 6(9):2716-9. PubMed ID: 1612296
[TBL] [Abstract][Full Text] [Related]
15. Immunotargeting of liposomes containing lipophilic antitumor prodrugs.
Mori A; Kennel SJ; Huang L
Pharm Res; 1993 Apr; 10(4):507-14. PubMed ID: 8483832
[TBL] [Abstract][Full Text] [Related]
16. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
Moribe K; Maruyama K; Iwatsuru M
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1683-7. PubMed ID: 9353897
[TBL] [Abstract][Full Text] [Related]
17. Influence of lipopolymer concentration on liposome degradation and blood clearance.
Vermehren C; Jørgensen K; Frokjaer S
Int J Pharm; 1999 Jun; 183(1):13-6. PubMed ID: 10361145
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.
Parr MJ; Ansell SM; Choi LS; Cullis PR
Biochim Biophys Acta; 1994 Oct; 1195(1):21-30. PubMed ID: 7918562
[TBL] [Abstract][Full Text] [Related]
19. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidylethanolamine liposomes.
Litzinger DC; Huang L
Biochim Biophys Acta; 1992 Feb; 1104(1):179-87. PubMed ID: 1550846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
